INSM – insmed, inc. (US:NASDAQ)

News

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insmed Incorporated - INSM
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insmed Incorporated - INSM
Insmed CEO Will Lewis talks its rare disease drug pipeline [CNBC]
Insmed (NASDAQ:INSM) was given a new $205.00 price target on by analysts at Truist Financial Corporation.
Is It Too Late To Reassess Insmed (INSM) After Its Huge Share Price Surge? [Yahoo! Finance]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com